annual ROE:
141.12%-28.66%(-16.88%)Summary
- As of today (September 14, 2025), AKBA annual return on equity is 141.12%, with the most recent change of -28.66% (-16.88%) on December 31, 2024.
- During the last 3 years, AKBA annual ROE has risen by +316.49% (+180.47%).
- AKBA annual ROE is now -16.88% below its all-time high of 169.78%, reached on December 31, 2023.
Performance
AKBA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
318.76%+152.11%(+91.28%)Summary
- As of today (September 14, 2025), AKBA quarterly return on equity is 318.76%, with the most recent change of +152.11% (+91.28%) on June 1, 2025.
- Over the past year, AKBA quarterly ROE has increased by +195.29% (+158.17%).
- AKBA quarterly ROE is now -18.47% below its all-time high of 390.98%, reached on September 30, 2013.
Performance
AKBA quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
AKBA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -16.9% | +158.2% |
| 3 y3 years | +180.5% | +286.2% |
| 5 y5 years | +360.0% | +455.2% |
AKBA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -16.9% | +159.3% | -2.8% | +125.3% |
| 5 y | 5-year | -16.9% | +159.3% | -2.8% | +125.3% |
| alltime | all time | -16.9% | +123.4% | -18.5% | +101.1% |
AKBA ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | 318.76%(+91.3%) |
| Mar 2025 | - | 166.65%(-3.6%) |
| Dec 2024 | 141.12%(-16.9%) | 172.88%(+33.4%) |
| Sep 2024 | - | 129.56%(+4.9%) |
| Jun 2024 | - | 123.47%(-11.0%) |
| Mar 2024 | - | 138.74%(-25.7%) |
| Dec 2023 | 169.78%(-171.4%) | 186.84%(-43.0%) |
| Sep 2023 | - | 327.82%(-126.0%) |
| Jun 2023 | - | -1259.94%(+286.4%) |
| Mar 2023 | - | -326.04%(+22.9%) |
| Dec 2022 | -237.83%(+35.6%) | -265.23%(+5.9%) |
| Sep 2022 | - | -250.35%(+46.2%) |
| Jun 2022 | - | -171.21%(-22.0%) |
| Mar 2022 | - | -219.61%(+32.0%) |
| Dec 2021 | -175.37%(+46.9%) | -166.43%(+21.4%) |
| Sep 2021 | - | -137.07%(+21.2%) |
| Jun 2021 | - | -113.10%(-10.8%) |
| Mar 2021 | - | -126.86%(+14.3%) |
| Dec 2020 | -119.39%(+120.0%) | -111.02%(+10.6%) |
| Sep 2020 | - | -100.40%(+11.9%) |
| Jun 2020 | - | -89.74%(+57.0%) |
| Mar 2020 | - | -57.15%(+5.6%) |
| Dec 2019 | -54.27%(+43.3%) | -54.11%(+2.9%) |
| Sep 2019 | - | -52.58%(-1.5%) |
| Jun 2019 | - | -53.37%(-5.3%) |
| Mar 2019 | - | -56.38%(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -37.86%(-51.0%) | -56.80%(+21.6%) |
| Sep 2018 | - | -46.71%(-7.8%) |
| Jun 2018 | - | -50.66%(-2.2%) |
| Mar 2018 | - | -51.81%(-46.8%) |
| Dec 2017 | -77.27%(-43.3%) | -97.40%(-45.4%) |
| Sep 2017 | - | -178.29%(-0.9%) |
| Jun 2017 | - | -179.91%(+16.6%) |
| Mar 2017 | - | -154.34%(+36.6%) |
| Dec 2016 | -136.35%(+163.9%) | -112.96%(+30.1%) |
| Sep 2016 | - | -86.81%(+25.1%) |
| Jun 2016 | - | -69.38%(+26.0%) |
| Mar 2016 | - | -55.06%(+13.3%) |
| Dec 2015 | -51.66%(-6.0%) | -48.58%(+15.2%) |
| Sep 2015 | - | -42.17%(+19.8%) |
| Jun 2015 | - | -35.21%(+4.0%) |
| Mar 2015 | - | -33.85%(-81.4%) |
| Dec 2014 | -54.93%(-41.4%) | -182.23%(-12.3%) |
| Sep 2014 | - | -207.72%(-27.6%) |
| Jun 2014 | - | -286.78%(-99.0%) |
| Mar 2014 | - | -28.21K%(<-9900.0%) |
| Dec 2013 | -93.80%(-84.5%) | 12.74%(-96.7%) |
| Sep 2013 | - | 390.98%(+56.2%) |
| Jun 2013 | - | 250.36%(+73.0%) |
| Mar 2013 | - | 144.73%(+19.1%) |
| Dec 2012 | -603.82%(+78.3%) | - |
| Dec 2012 | - | 121.56% |
| Dec 2011 | -338.65% | - |
FAQ
- What is Akebia Therapeutics, Inc. annual return on equity?
- What is the all time high annual ROE for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual ROE year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly return on equity?
- What is the all time high quarterly ROE for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly ROE year-on-year change?
What is Akebia Therapeutics, Inc. annual return on equity?
The current annual ROE of AKBA is 141.12%
What is the all time high annual ROE for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual return on equity is 169.78%
What is Akebia Therapeutics, Inc. annual ROE year-on-year change?
Over the past year, AKBA annual return on equity has changed by -28.66% (-16.88%)
What is Akebia Therapeutics, Inc. quarterly return on equity?
The current quarterly ROE of AKBA is 318.76%
What is the all time high quarterly ROE for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly return on equity is 390.98%
What is Akebia Therapeutics, Inc. quarterly ROE year-on-year change?
Over the past year, AKBA quarterly return on equity has changed by +195.29% (+158.17%)